Urology departments in England and Wales have seen an increase in users admitted for bladder inflammation caused by ketamine ...
1hon MSN
Millions warned as cases of deadly pet threat spike across Aussie suburbs: 'Be extra vigilant'
As temperatures soar around the country, Australian pet owners are being urged to stay vigilant when it comes to tick ...
FROM nausea to constipation, ‘Ozempic teeth’ to ‘Ozem-d*ck’, we’ve heard it all when it comes to fat jab side effects. But ...
Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...
BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious ...
The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...
Less than four months after rejecting Sentynl Therapeutics and Cyprium Therapeutics’ treatment for Menkes disease, the FDA ...
22hon MSN
Millions urged to stay alert as tiny but deadly pest threatens pets in Aussie suburbs: 'Frightening'
Sydney Animal Hospitals vet Dr Zoe Pimlott said ticks are a year-round threat, but their numbers surge in summer when warm, wet conditions create the ideal environment for them to thrive. In an ...
The NHS has warned that vitamin B12 deficiency can cause neurological problems that may mimic dementia symptoms ...
Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback